Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy.
Petru E, Andel J, Angleitner-Boubenizek L, Steger G, Bernhart M, Busch K, Gehmacher O, Hernler T, Kastner U, Lanz-Veit A, Pluschnigg U, Polachova J, Rohde M, Schiller L, Schramböck R, Stangl W, Thödtmann R, Zabernigg A.
Petru E, et al.
Wien Med Wochenschr. 2008;158(5-6):169-73. doi: 10.1007/s10354-008-0515-1.
Wien Med Wochenschr. 2008.
PMID: 18421559